120 results about "Medical therapy" patented technology

The systems, devices, and methods presented herein use a blood pump to obtain measurements of cardiac function. The system can quantify the functioning of the native heart by measuring certain parameters / signals such as aortic pressure or motor current, then calculate and display one or more cardiac parameters and heart function parameters, such as left ventricular pressure, left ventricular end diastolic pressure, or cardiac power output. These parameters provide valuable information to a user regarding current cardiac function, as well as positioning and function of the blood pump. In some embodiments, the system can act as a diagnostic and therapeutic tool. Providing cardiac parameters in real-time, along with warnings about adverse effects and recommendations to support cardiac function, such as increasing or decreasing the volumetric flow rate of blood pumped by the device, administering pharmaceutical therapies, and / or repositioning the blood pump allow clinicians to better support and treat cardiovascular disease.

The invention relates to novel compositions and methods of using maribavir which enhance its effectiveness in medical therapy, as well as to maribavir isomers and methods of use thereof for counteracting the potentially adverse effects of maribavir isomerization in vivo in the event it occurs.

The present invention generally relates to novel pharmaceutical formulations containing 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4] oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide, methods of preparation thereof and their use in medical therapy.

The present disclosure relates to novel lamotrigine salts, co-crystals, and compositions. In some embodiments, the lamotrigine salt is a lamotrigine dicarboxylic acid salt or hydrate or solvate thereof. In some embodiments, the lamotrigine co-crystal is a co-crystal of lamotrigine and a dicarboxylic acid, or a hydrate or solvate thereof. In some embodiments, the compositions comprise lamotrigine or a salt or co-crystal thereof, or a hydrate or solvate thereof. In some embodiments, the composition is in the form of a powder. In some embodiments, the composition is in the form of a liquid. The present disclosure also relates to methods of preparation and use in medical therapy, for example, for the treatment of a subject with epilepsy or bipolar disorder.

Disclosed herein are systems and methods for remotely monitoring and / or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and / or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and / or notifications and / or control of medical device therapy. The system can include permissions to determine who, how and when information and / or control is shared that can consider factors such as time, location and relationship with the patient.

The invention particularly relates to a pet food containing Chinese herbal medicines and capable of maintaining intestinal health of pets and a preparation method of the pet food. The pet food comprises an inner-layer structure and an outer-layer structure covering the surface of the inner-layer structure, wherein the inner-layer structure is a ball intermediate prepared by mixing Chinese herbal medicine powder, a nutritional additive and a binder; the outer layer structure comprises a meat source; the binder comprises a cartilage hydrolysate; the Chinese herbal medicine powder in the inner layer of the pet food is Chinese herbal medicine powder for improving gastrointestinal functions; the nutritional additive comprises inactivated probiotics, prebiotics, compound digestive enzymes, chicken liver hydrolyzed powder and auxiliary materials; by optimizing the formula and the process, the palatability of the pet food is ensured, the digestion and absorption conditions of pets are improved, the intestinal problems can be effectively prevented and treated, nutrition and drug therapy are integrated, and the overall health of the pets is promoted; good commercial application prospects are realized.

An AI-based system and method for determining medical therapies is disclosed. The AI-based method includes receiving patient multiomics raw data, extracting one or more reports from the patient multiomics raw data, and detecting one or more genome variants in the patient. Further, the AI-based method includes determining if the one or more genome variants are one or more known variants or one or more unknown variants, determining if the one or more genome variants are one or more coding variants or one or more non-coding variants, and determining if the patient is suffering from a functional loss or a functional excess. The AI-based method includes generating one or more rescue recommendations, determining one or more medical therapies for the patient, and outputting the one or more rescue recommendations and the one or more medical therapies to one or more electronic devices associated with the user.

The present invention relates to semaglutide for use in weight management.

The invention relates to the technical field of traditional Chinese medicine treatment devices, and discloses a Chinese herbal medicine hot compress device for pediatric traditional Chinese medicine treatment, which comprises a support frame, the top of the support frame is fixedly connected with a heating box, the heating box is provided with a Chinese herbal medicine hot compress part, the heating box is also provided with a medicine residue pouring part, and the medicine residue pouring part is provided with a driving part; water in the heating box is heated through the electric heating rod to generate steam, the steam carries effective components of Chinese herbal medicine to act on the hot compress sponge, then hot compress is conducted on a child patient, stable hot compress can be achieved, meanwhile, steam hot compress is utilized, thermal therapy and medical therapy are combined, the physical therapy effect is enhanced, the steam hot compress mode is adopted, and the physical therapy effect is improved. Potential safety hazards such as aging and electric leakage of the heating wire are avoided; a medicine residue pouring-out part and a driving part are arranged, a threaded rod is driven to rotate through a driving motor, a guide round block is made to move, then a vertical guide column is driven to move in a transverse guide groove and a spiral guide groove, and horizontal movement and overturning of a containing cylinder are achieved.

The utility model relates to an adjustable fixable perineum cold patch which comprises a metering type nursing pad and a medicine pad, the medicine pad is arranged at the position, corresponding to the perineum of a puerpera, of the metering type nursing pad, an adjustable fastening structure is arranged on the metering type nursing pad and used for firmly wearing the metering type nursing pad, and the medicine pad comprises a sanitary towel and an adhesive area. Liquid medicine is adsorbed on the front face of the sanitary towel, an adhesive area is arranged on the back face of the sanitary towel, the sanitary towel adheres to the metering type nursing pad through the adhesive area on the back face of the sanitary towel, and the liquid medicine is prepared from magnesium sulfate, normal saline and lidocaine. The cold compress effect is provided for the perineum wound of a puerpera through the frozen medicine pad, the pain of the perineum wound is relieved, in addition, the medicine pad has the medicine effect, medicine treatment can be provided for the perineum wound of the puerpera, subtraction of perineum edema is facilitated, the double effects of cold compress and edema removal are achieved through combination of the medicine pad and the medicine pad, and the pain of the puerpera can be further relieved; the recovery of the perineum is accelerated.

To provide a method of treating a patient with chronic heart failure using a medicament comprising neuregulin.SOLUTION: A companion diagnostic test is first performed on each patient prior to treatment, and the appropriate treatment is provided to each patient according to the companion diagnostic test results. If the test results are within a preferred therapeutic range for treatment, the patient is suitable for treatment of heart failure by administration of an effective amount of neuregulin.SELECTED DRAWING: None

The invention belongs to the field of new application of medicines, and particularly relates to application of triptolide in preparation of medicines for treating diabetic vascular obstruction complications. Diabetes vascular obstruction is a common serious complication of diabetes and can cause various tissue injuries such as cardiovascular diseases, nephropathy and retinopathy. Experiments prove that the triptolide can remarkably improve the problems of blood vessel blockage, blood flow slowing, abnormal neovascularization and the like caused in a high-glucose environment, and meanwhile, the expression of blood glucose related indexes (such as Glucose and HbA1c) and inflammatory factors (such as TNF-alpha and IL-1beta) is reduced. In addition, triptolide can also protect pancreas from high glucose damage and improve functions of pancreatic beta cells. According to the invention, the clinical application range of the triptolide is expanded, and a new candidate substance is provided for drug treatment of diabetic vascular complications.

A method of conducting operations for an IPG adapted to provide electrical pulses to tissue of a patient for medical therapy is provided. The IPG provides the medical therapy according to pulse parameter data executed according to an execution path. The method can include identifying a root node repeated within the execution path of a first set of the pulse parameter data, identifying a stimulation pulse pattern repeated in the first set between occurrences of the root node, replacing the repeated pattern with (a) a single instance and a recurrence count or (b) a pointer to a reference pattern to generate a second set of the pulse parameter data, and communicating the second set between the external controller and the IPG and / or storing the second set within a memory of the IPG.

The invention relates to novel crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-(.beta.-L-ribofuranosyl)-1H-benzimidazo-le (Maribavir), pharmaceutical compositions thereof and their use in medical therapy.

A system and method for formulating a medical treatment effluent by performing plasma reactions creating a plasma area in a gas adjacent to a liquid. An embodiment of the plasma reactor includes a housing with an internal reaction chamber, first and second inlet paths to the reaction chamber, and electrodes for producing an electric field. The system may optionally further include a pre-ionization electrode and pre-ionization electric field for pre-ionizing a feed gas prior to entry into a reaction chamber. The reactor uses plasma to ionize gas adjacent with the liquid. The ionized gas reacts with the liquid to form an effluent. Exemplary medical treatments include: immunization (immuno) therapy; wound treatment; cancer treatment; and disinfectant applications.

The application belongs to the technical field of medical treatment and specifically relates to an auxiliary instrument for chest trauma repair, which comprises a main body, a wearing assembly, a fixing assembly fixedly connected to the rear side of the wearing assembly, a replacement assembly, a covering assembly fixedly connected to the wearing assembly, a displacement assembly fixedly connected to the middle part of the covering assembly, a massage assembly fixedly connected to the wearing assembly and a medicine releasing assembly fixedly connected to the wearing assembly. The auxiliary instrument can quickly disassemble and replace the cloth adhering to the wound, can electrically massage the muscles near the wound, can adjust the electric shock position according to the size of the wound, can continuously release medicine to the wound, can continuously treat the wound with the medicine and can improve the recovery effect.

The present invention relates to the field of medical therapy of lesions detrimental to a body. The system is capable of treatment with a non-invasive, ionizing kV energy radiation source. Locally focused energy can be used to definitively treat, or as an adjuvant to enhance immune modulators, to eliminate tumors. Distributed external beam entry points produce a significant advantageous dose profile at depth as intersecting beams accumulate in a narrow focus to treat a selected volume. Targeted disease may have enhanced sensitivity to the radiation by taking up an ionizing-radiation, treatment-localizing agent. This increases the effectiveness of an energy dose in the lesion. The pattern of beam output is effectively directed towards a desired location and kV x-rays traveling towards undesired locations, such as healthy tissue, are quenched. Targeting a lesion within the body with volumetrically discrete energy dose deposition can beneficially impact harmful lesions. Aiming the beam at a pathologic target is done while moving an x-ray source mechanically around a patient to distribute surface dose. The purpose of the focused energy deposition is to destroy and disable pathologic physiology, such as malignant masses. More specifically this invention relates to a system, which optimizes delivery of ionizing kV beams to a lesion alone or one containing treatment-localizing agents in higher concentration than the surrounding normal tissues. Thereby an optimal delivery of ionizing radiation becomes more destructive to a mass of abnormal cells upon interaction with the targeted site.

This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions. The inhibitors are pyrimidine-based N-heterocyclic compounds of formula:

The invention relates to the technical field of medical instruments, in particular to a medical medicine quantitative infusion device which comprises an intravenous needle, a Luer taper liquid medicine filter, a bottle stopper puncture outfit, a Murphy type drip chamber, an infusion hose and a flow rate adjusting mechanism. An automatic liquid stopping mechanism is arranged in the Murphy type drip chamber and comprises a cylindrical shell fixedly connected to the inner bottom wall of the Murphy type drip chamber. By arranging the flow speed adjusting mechanism, the abutting arc block can be driven to stably move along the guide rod by rotating a flow speed adjusting knob, an infusion hose is accurately extruded to change the diameter of a pipeline, fine adjustment of the infusion flow speed of liquid medicine is achieved, and compared with a traditional speed regulator, the self-locking characteristic is better; the problem that the infusion speed is too high or too low due to poor stability of a speed regulator is effectively solved, the infusion speed can be flexibly set according to the medicine type, the illness state of a patient and the tolerance degree, the accuracy of the medicine infusion dosage and speed is guaranteed, and the medicine treatment effect is improved.

The invention discloses a traditional Chinese medicine insole capable of activating blood and promoting qi circulation and a preparation method thereof, and relates to the technical field of traditional Chinese medicine insole preparation, an insole body is made of a mixed foaming material, and the mixed foaming material is obtained by stirring and foaming traditional Chinese medicine powder and a liquid polyether material. According to the traditional Chinese medicine insole with the blood activating and qi promoting functions and the preparation method thereof, traditional Chinese medicine powder comprises 21 kinds of medicinal materials with the blood activating and qi promoting functions such as folium artemisiae argyi, radix paeoniae rubra and rhizoma curcumae longae, and the medicinal materials continuously act on the foot through skin permeation and smell fumigation; meanwhile, the medical magnets at the acupuncture points of the feet form magnetic field stimulation and cooperate with traditional Chinese medicine ingredients to promote local blood circulation, discomfort such as lower limb soreness and distension and numbness caused by qi and blood stasis is relieved, and dual conditioning of medical therapy and magnetic therapy is achieved.

The invention discloses a medicated diet composition for improving haemorrhoids and a preparation method thereof, and belongs to the field of traditional Chinese medicine, the medicated diet composition is specially used for qi deficiency and blood deficiency type haemorrhoids, and the medicated diet composition is prepared from the following raw materials in parts by mass: 15-30 parts of hairyvein agrimony, 50-80 parts of streaky pork, 15-30 parts of astragalus membranaceus, 10-20 parts of angelica sinensis, 6-10 parts of rhizoma cimicifugae, 100-150 parts of Chinese yam, 6-10 parts of pericarpium citri reticulatae and 10-15 parts of hawthorn. The traditional Chinese medicine composition realizes precise conditioning of homology of medicine and food, not only exerts the treatment effects of tonifying qi and lifting, nourishing blood and stopping bleeding through the medicinal materials, but also supplements nutrition and assists in improving the qi and blood deficiency state by means of food materials, solves the problem that patients of the type need long-term independent conditioning after conventional medicine treatment, and gives consideration to the synergistic effect of treatment and deficiency tonifying.

A drug delivery device for conducting a medical therapy includes a housing with an exit port opening, and an exit port assembly, where said exit port assembly includes a rigid exit port sealing holder and a soft exit port sealing, and provides both a fluid-tight closure of the exit port opening and a fluid-tight connection between the housing and the rigid exit port sealing holder.

A system and method for residual voltage monitoring and extracting ETI load parametric data relative to one or more electrodes of an implanted stimulation lead system associated with an IPG for diagnostics and for providing a medical therapy to a patient using electrical pulses. Responsive to comparing the measured residual voltages against estimated residual voltages obtained based on the ETI load parametric data, appropriate corrective action may be effectuated.

In one embodiment, an implantable medical device (IMD) comprises: therapeutic circuitry for controlling delivery of a medical therapy to a patient; a processor for controlling the IMD according to executable code; wireless communication circuitry for conducting wireless communications; and memory for storing data and executable code, wherein the executable comprises code for causing the processor to (1) communicate with an external programming device to define therapeutic settings for operation of the IMD, (2) perform validation operations on one or more instances of therapeutic settings by determining whether a respective instance of therapeutic settings is accompanied by permanent validation data or temporary validation data, wherein the validation operations comprise analyzing temporary validation data against at least one key of a plurality of cryptographic keys stored by the IMD.

The present invention relates to: a tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl) isoxazol-4-yl) methoxyl)-N-(tetrahydropyran-4-yl) pyridazine-3-carboxamide; and a pharmaceutical composition comprising the tablet. A process for the preparation of the tablet; a cartridge containing the tablet; and the use of the tablet in medical treatment.

The invention relates to the technical field of home rehabilitation nursing, and discloses an intelligent home nursing management method based on intelligent medical treatment, which comprises the following steps: acquiring related illness state and physiological data of a patient, automatically generating a rehabilitation model, judging the rehabilitation process of the patient, and when the rehabilitation process is far away from the estimated data, performing early warning and adjustment by a system in time. According to the door-to-door nursing intelligent management method based on intelligent medical treatment, the tolerance degree of a patient to pain is judged, rehabilitation recommendation is intelligently performed, a single-day change curve is generated according to heart rate changes of the patient under different rehabilitation items and drug treatment, the rehabilitation process of the patient is judged, and when the rehabilitation process of the patient is greatly different from an estimated model, the patient is reminded to go to the patient. The system can timely prompt an attending physician of the patient to adjust rehabilitation items, facilitates rehabilitation of the patient and work of nursing personnel, improves safety and effectiveness of rehabilitation of the patient, promotes development of personalized medical treatment, improves medical service quality, reduces unnecessary medical cost, and improves life quality of the patient.

This application is generally related to systems and methods for providing a medical therapy to a patient by tracking patient activity and adjusting medical therapy based on occurrence of different types of activities performed by the patient while automatically rescheduling stimulation programs based on detected patient activity.

This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions. The inhibitors are pyrimidine-based N-heterocyclic compounds of formula:

Providing novel compounds for use in the treatment or prevention of cancer and other proliferative conditions SOLUTION: The present invention relates to novel compounds for use, for example, in the treatment or prevention of cancers and other proliferation conditions characterized by cells expressing cytochrome P4501B1 (CYP1B1) and allelic variants thereof. The invention also provides pharmaceutical compositions comprising one or more such compounds for use in medical therapy, for example in the treatment or prophylaxis of cancer or other proliferative conditions, as well as methods of treating cancer or other conditions in a human or non-human animal patient. The present invention also provides methods of identifying novel compounds for use in the treatment or prevention of cancers and other prohferative conditions characterized by cells that express, for example, CYP1B1 and allelic variants thereof. The invention also provides a method for determining the effectiveness of a compound of the invention in treating cancer.SELECTED DRAWING: Figure 1

An assembly and method for housing and securing exposed dose adjustment control mechanisms of medical devices used to administer various medical therapies, is provided. In an exemplary embodiment, the inventive assembly and method serve to house and secure exposed dose adjustment control mechanisms of oxygen concentrators used to provide oxygen therapy. The inventive assembly, which securely encloses a dose adjustment control mechanism, permitting access only to select individuals, is made up of a cup-shaped hollow member having a through-hole in a distal wall, and a lid. The cup-shaped hollow member and the lid are held together by a hinge or fastening means, and fastening / locking means.